logo

For the Inventor, By the Inventor

Shiga, Japan

Makoto Urushitani

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Universitè Laval. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makoto Urushitani. Retrieved from https://idiyas.com/inventor/makoto-urushitani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal2 out of 304 
 
Universitè Laval
 patents

Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
1. 9266963 - Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities (2016-02-23),
2. 8759029 - Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities (2014-06-24),

Title: The Innovations of Makoto Urushitani

Introduction

Makoto Urushitani is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on addressing diseases associated with abnormalities in superoxide dismutase 1 (SOD1).

Latest Patents

Urushitani holds 2 patents related to his innovative research. His latest patents involve antibodies that specifically bind to abnormal SOD1, neutralizing its pathological effects when administered to humans. These monoclonal antibodies are produced by hybridoma cell lines, which were deposited with the International Depositary Authority of Canada on August 29, 2006. The applications of these antibodies extend to the treatment, prevention, and diagnosis of neurodegenerative diseases such as Amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer's disease.

Career Highlights

Urushitani is affiliated with Université Laval, where he continues to advance his research in biotechnology. His work has garnered attention for its potential impact on treating serious neurological conditions.

Collaborations

One of his notable collaborators is Jean-Pierre Julien, with whom he has worked on various research projects aimed at understanding and combating neurodegenerative diseases.

Conclusion

Makoto Urushitani's contributions to the field of biotechnology through his innovative patents highlight the importance of research in developing treatments for debilitating diseases. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…